Related Experiment Video
Updated: Mar 24, 2026

13:47
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
20.0K
Evolution of Cell-Type-Specific RNA Aptamers Via Live Cell-Based SELEX
Jiehua Zhou1, John J Rossi2,3
1Division of Molecular and Cellular Biology, Beckman Research Institute of City of Hope, 1500 East Duarte Rd, Duarte, CA, 91010, USA.
Methods in Molecular Biology (Clifton, N.J.)
|March 12, 2016
Summary
Live cell-based Systematic Evolution of Ligand EXponential enrichment (SELEX) effectively identifies aptamers for cell-surface targets. This method is ideal for complex proteins, enabling the selection of RNA aptamers against human CCR5 using high-throughput sequencing.
Area of Science:
- Biotechnology
- Molecular Biology
- Genomics
Background:
- Live cell-based SELEX is a powerful method for aptamer discovery against cell-surface targets.
- It is particularly useful for targets that are difficult to express or purify in vitro.
- This approach allows for the selection of aptamers that recognize native protein conformations.
Purpose of the Study:
- To describe the evolution of cell-type-specific RNA aptamers targeting the human CCR5.
- To demonstrate the utility of live cell-based SELEX for identifying aptamers against specific cell surface proteins.
- To combine SELEX with high-throughput sequencing and bioinformatics for aptamer discovery.
Main Methods:
- Live cell-based Systematic Evolution of Ligand EXponential enrichment (SELEX) was employed.
- High-throughput sequencing (HTS) was used for aptamer identification and characterization.
- Bioinformatics analysis was performed to refine aptamer selection and specificity.
Main Results:
- Cell-type-specific RNA aptamers targeting human CCR5 were successfully evolved.
- The study demonstrated the feasibility of using live cell-based SELEX for complex targets.
- Integration of HTS and bioinformatics enhanced the efficiency of aptamer selection.
Conclusions:
- Live cell-based SELEX is an effective strategy for aptamer selection against cell-surface targets, including challenging proteins.
- The developed aptamers can be specific for cell types expressing CCR5.
- This integrated approach provides a robust platform for aptamer discovery in various biological applications.

